874440-85-4

Basic information

• Product Name: ETHYL 4-BENZYLPIPERIDINE-4-CARBOXYLATE
• Synonyms: ETHYL 4-BENZYLPIPERIDINE-4-CARBOXYLATE
• CAS NO: 874440-85-4
• Molecular Formula: C₁₅H₂₁NO₂
• Molecular Weight: 247.33
• Mol File: 874440-85-4.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ETHYL 4-BENZYLPIPERIDINE-4-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-BENZYLPIPERIDINE-4-CARBOXYLATE(874440-85-4)
• EPA Substance Registry System: ETHYL 4-BENZYLPIPERIDINE-4-CARBOXYLATE(874440-85-4)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 874440-85-4(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 142851-03-4 1-tert-butyl 4-ethyl piperidine-1,4-dicarboxylate 
• 1126-09-6 4-carbethoxypiperidine 
• 167263-10-7 4-benzyl-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-ethyl ester 

Downstream Products

• 1261253-29-5 ethyl 1-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-acetoxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carbonyl)-4-benzylcypiperidine-4-carboxylate 
• 1261253-30-8 ethyl 4-benzyl-4-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carbonyl)piperidine-4-carboxylate 
• 1261253-31-9 4-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(4-benzyl-4-(ethoxycarbonyl)piperidine-1-carbonyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-yloxy)-2,2-dimethyl-4-oxobutanoic acid 
• 546085-37-4 (4-benzyl-piperidin-4-yl)-methanol 
• 935260-23-4 4-ethoxycarbonyl-4-benzyl-1-nitrosopiperidine 
• 1372547-59-5 Ethyl 4-benzyl-1-(5-bromopyrimidin-2-yl)piperidine-4-carboxylate 

Relevant articles and documents

SPIRO AZETIDINE ISOXAZOLE DERIVATIVES AND THEIR USE AS SSTR5 ANTAGONISTS

Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

Compounds of general formula (I) and compositions comprising compounds of general formula (I) that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.